CryoPort, Inc. (CYRX) Given New $10.00 Price Target at Needham & Company LLC
CryoPort, Inc. (NASDAQ:CYRX) had its price objective raised by Needham & Company LLC from $8.50 to $10.00 in a research note issued to investors on Wednesday morning. They currently have a buy rating on the stock.
Other equities analysts also recently issued research reports about the company. Janney Montgomery Scott set a $8.00 price objective on CryoPort and gave the company a buy rating in a research report on Wednesday, July 26th. ValuEngine upgraded CryoPort from a sell rating to a hold rating in a research report on Thursday, May 11th. Finally, Cowen and Company lifted their price objective on CryoPort from $5.50 to $7.50 and gave the company an outperform rating in a research report on Wednesday, August 9th.
CryoPort (NASDAQ:CYRX) opened at 6.85 on Wednesday. The stock has a 50 day moving average of $6.53 and a 200-day moving average of $4.15. The firm’s market capitalization is $169.02 million. CryoPort has a one year low of $1.80 and a one year high of $8.23.
CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Tuesday, August 8th. The company reported ($0.08) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. CryoPort had a negative return on equity of 67.75% and a negative net margin of 102.89%. The business had revenue of $2.92 million for the quarter, compared to analyst estimates of $2.84 million. On average, equities analysts predict that CryoPort will post ($0.72) EPS for the current year.
A number of institutional investors have recently modified their holdings of the stock. Northern Trust Corp increased its position in shares of CryoPort by 105.0% in the second quarter. Northern Trust Corp now owns 22,179 shares of the company’s stock valued at $109,000 after buying an additional 11,358 shares during the last quarter. BerganKDV Wealth Management LLC increased its position in shares of CryoPort by 157.5% in the second quarter. BerganKDV Wealth Management LLC now owns 25,750 shares of the company’s stock valued at $127,000 after buying an additional 15,750 shares during the last quarter. EAM Investors LLC acquired a new position in shares of CryoPort during the second quarter valued at about $552,000. D.A. Davidson & CO. increased its position in shares of CryoPort by 16.6% in the second quarter. D.A. Davidson & CO. now owns 137,000 shares of the company’s stock valued at $674,000 after buying an additional 19,500 shares during the last quarter. Finally, Taylor Wealth Management Partners acquired a new position in shares of CryoPort during the second quarter valued at about $1,851,000. Hedge funds and other institutional investors own 12.05% of the company’s stock.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.